The Invisible Enemy – How Human Papillomaviruses Avoid Recognition and Clearance by the Host Immune System



Agnieszka K Grabowska, Angelika B Riemer*
Immunotherapy and -prevention, German Cancer Research Center (DKFZ), Heidelberg, Germany


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 1134
Abstract HTML Views: 423
PDF Downloads: 96
Total Views/Downloads: 1653
Unique Statistics:

Full-Text HTML Views: 430
Abstract HTML Views: 231
PDF Downloads: 76
Total Views/Downloads: 737



© Grabowska and Riemer.; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at Immunotherapy and -prevention, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany; Tel: +49 6221 42 3820; Fax: +49 6221 42 4852; E-mail: a.riemer@dkfz.de


Abstract

Human papillomavirus (HPV) needs to persist in squamous epithelia for a certain amount of time to complete its reproductive cycle. Therefore, the virus has evolved multiple immune evasion strategies. The interplay of these immune evasion mechanisms with the host immune system decides whether a HPV infection is cleared or becomes persistent. Clearance of HPV-induced lesions is mediated by a cellular immune response, consisting of both cytotoxic T lymphocyte and T helper cell responses. Persistent HPV infection, on the other hand, is the single most important risk factor for the development of HPV-associated premalignant lesions and HPV-driven cancers. This article reviews the immune evasion mechanisms employed by high-risk HPVs to escape host immune recognition and attack.

Keywords: Cancer, human papillomavirus (HPV), immune response, immune evasion..